FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

458851000000108: [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use (disorder)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2015. Module: SNOMED CT United Kingdom clinical extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    805871000000111 [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom clinical extension module
    864791000000116 [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use (disorder) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom clinical extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Is a [X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use false Inferred relationship Existential restriction modifier
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Is a Hematological agents adverse reaction false Inferred relationship Existential restriction modifier
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Causative agent Hematologic agent false Inferred relationship Existential restriction modifier
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Is a [X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    [X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Vitamin B12, folic acid and other anti-megaloblastic anaemia preparations causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Iron preparations and other anti-hypochromic-anemia preparations causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Anticoagulants causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Other and unspecified agents affecting blood constituents causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Natural blood and blood products causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Plasma substitutes causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Thrombolytic drugs causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Iron preparations and other anti-hypochromic-anemia preparations causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Other and unspecified agents affecting blood constituents causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Thrombolytic drugs causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier
    [X]Plasma substitutes causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start